[HTML][HTML] NTRK gene fusions as novel targets of cancer therapy across multiple tumour types

A Amatu, A Sartore-Bianchi, S Siena - ESMO open, 2016 - Elsevier
The tropomyosin receptor kinase (Trk) receptor family comprises 3 transmembrane proteins
referred to as Trk A, B and C (TrkA, TrkB and TrkC) receptors that are encoded by the …

Targeting TRK family proteins in cancer

YB Khotskaya, VR Holla, AF Farago, KRM Shaw… - Pharmacology & …, 2017 - Elsevier
The tropomyosin receptor kinase (TRK) family includes TRKA, TRKB, and TRKC proteins,
which are encoded by NTRK1, NTRK2 and NTRK3 genes, respectively. Binding of …

A review of NTRK fusions in cancer

CA Manea, DC Badiu, IC Ploscaru… - Annals of Medicine …, 2022 - journals.lww.com
The family of the neurotrophic tropomyosin kinase receptors (NTRK or TRK) is a part of the
transmembrane tyrosine kinases responsible for neuronal development. The members of …

Inhibiting TRK proteins in clinical cancer therapy

AM Lange, HW Lo - Cancers, 2018 - mdpi.com
Gene rearrangements resulting in the aberrant activity of tyrosine kinases have been
identified as drivers of oncogenesis in a variety of cancers. The tropomyosin receptor kinase …

[HTML][HTML] Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer

A Amatu, A Sartore-Bianchi, K Bencardino… - Annals of …, 2019 - Elsevier
The tropomyosin receptor kinase (TRK) family of receptor tyrosine kinases are encoded by
NTRK genes and have a role in the development and normal functioning of the nervous …

[HTML][HTML] NTRK insights: best practices for pathologists

JF Hechtman - Modern Pathology, 2022 - Elsevier
Since the discovery of an oncogenic tropomyosin-receptor kinase (TRK) fusion protein in the
early 1980s, our understanding of neurotrophic tropomyosin-receptor kinase (NTRK) …

Testing algorithm for identification of patients with TRK fusion cancer

F Penault-Llorca, ER Rudzinski… - Journal of clinical …, 2019 - jcp.bmj.com
The neurotrophic tyrosine receptor kinase (NTRK) gene family encodes three tropomyosin
receptor kinases (TRKA, TRKB, TRKC) that contribute to central and peripheral nervous …

[HTML][HTML] Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers

T Jiang, G Wang, Y Liu, L Feng, M Wang, J Liu… - … Pharmaceutica Sinica B, 2021 - Elsevier
Tropomyosin receptor kinase A, B and C (TRKA, TRKB and TRKC), which are well-known
members of the cell surface receptor tyrosine kinase (RTK) family, are encoded by the …

Emerging Targeted Therapy for Tumors with NTRK Fusion Proteins

ES Kheder, DS Hong - Clinical Cancer Research, 2018 - AACR
The oncogenesis-promoting role of chromosomal rearrangements for several hematologic
and solid malignancies is well recognized. However, identifying targetable, actionable, and …

Tropomyosin receptor kinase inhibitors for the treatment of TRK fusion cancer

TW Laetsch, DS Hong - Clinical Cancer Research, 2021 - AACR
Chromosomal rearrangements of NTRK1–3 resulting in gene fusions (NTRK gene fusions)
have been clinically validated as oncogenic drivers in a wide range of human cancers …